0001493152-19-008568.txt : 20190603
0001493152-19-008568.hdr.sgml : 20190603
20190603170011
ACCESSION NUMBER: 0001493152-19-008568
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190531
FILED AS OF DATE: 20190603
DATE AS OF CHANGE: 20190603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STERN ADAM K
CENTRAL INDEX KEY: 0001403497
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38022
FILM NUMBER: 19873961
MAIL ADDRESS:
STREET 1: STERN AEGIS VENTURES
STREET 2: 810 7TH AVENUE 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Matinas BioPharma Holdings, Inc.
CENTRAL INDEX KEY: 0001582554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463011414
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1545 ROUTE 206 SOUTH
STREET 2: SUITE 302
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: 908-443-1860
MAIL ADDRESS:
STREET 1: 1545 ROUTE 206 SOUTH
STREET 2: SUITE 302
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
ownership.xml
X0306
4
2019-05-31
0
0001582554
Matinas BioPharma Holdings, Inc.
MTNB
0001403497
STERN ADAM K
AEGIS CAPITAL CORP, ATTN: CASSEL SHAPIRO
810 SEVENTH AVE., 18TH FLOOR
NEW YORK
NY
10019
1
0
0
0
Common Stock, par value $0.0001 per share
2019-05-31
4
P
0
80000
0.94
A
3169483
I
Held by AKS Family Partners LP
Common Stock, par value $0.0001 per share
793992
D
Common Stock, par value $0.0001 per share
300000
I
Held by Pavilion Capital Partners Inc.
Common Stock, par value $0.0001 per share
300000
I
Held by Piper Ventures Partners LLC
Common Stock, par value $0.0001 per share
1750000
I
Held by AKS Family Foundation, Inc.
Common Stock, par value $0.0001 per share
600000
I
Held by SternAegis Ventures LLC Defined Benefit Pension Plan
Mr. Stern disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership by Mr. Stern of the reported securities for purposes of Section 16 or any other purpose.
The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.92 to $0.95, inclusive. The reporting person undertakes to provide to Matinas BioPharma Holdings, Inc., any security holder of Matinas BioPharma Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
/s/ Jerome D. Jabbour, attorney-in fact for Adam K. Stern
2019-06-03